NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $144,604,000 | +49.7% | 4,042,599 | +8.8% | 0.04% | +33.3% |
Q3 2014 | $96,572,000 | -19.5% | 3,714,312 | +2.3% | 0.03% | -20.6% |
Q2 2014 | $120,007,000 | +5.8% | 3,631,075 | -4.2% | 0.03% | 0.0% |
Q1 2014 | $113,417,000 | +1.4% | 3,789,420 | +2.9% | 0.03% | 0.0% |
Q4 2013 | $111,810,000 | -5.5% | 3,682,792 | -1.0% | 0.03% | -15.0% |
Q3 2013 | $118,347,000 | +141.4% | 3,720,449 | +14.7% | 0.04% | +122.2% |
Q2 2013 | $49,031,000 | – | 3,244,929 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 549,425 | $16,680,000 | 6.89% |
Opaleye Management Inc. | 205,000 | $5,945,000,000 | 4.67% |
Rhenman & Partners Asset Management AB | 240,000 | $7,286,000 | 2.85% |
SECTORAL ASSET MANAGEMENT INC | 1,774,919 | $53,887,000 | 2.32% |
Eventide Asset Management | 242,700 | $7,368,000 | 2.27% |
OAK RIDGE INVESTMENTS LLC | 2,713,717 | $82,389,000 | 2.16% |
First Light Asset Management, LLC | 68,245 | $2,072,000 | 1.76% |
Broadfin Capital, LLC | 400,000 | $12,144,000 | 1.60% |
Cupps Capital Management, LLC | 748,175 | $22,714,000 | 1.54% |
FCG ADVISORS, LLC | 70,651 | $2,145,000 | 1.45% |